HSBC Holdings’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,231
Closed -$432K 3130
2025
Q2
$432K Sell
3,231
-573
-15% -$62.9K ﹤0.01% 2224
2025
Q1
$254K Sell
3,804
-83,694
-96% -$5.76M ﹤0.01% 2481
2024
Q4
$5.45M Buy
87,498
+53,970
+161% +$5.02M ﹤0.01% 1106
2024
Q3
$5.26M Buy
33,528
+26,968
+411% +$4.16M ﹤0.01% 1103
2024
Q2
$987K Sell
6,560
-69,813
-91% -$8.37M ﹤0.01% 1691
2024
Q1
$5.65M Buy
76,373
+34,723
+83% +$2.86M ﹤0.01% 1066
2023
Q4
$3.29M Buy
41,650
+6,650
+19% +$401K ﹤0.01% 1296
2023
Q3
$1.92M Buy
+35,000
New +$2.52M ﹤0.01% 1470
2021
Q4
Sell
-35,020
Closed -$1.16M 3359
2021
Q3
$1.16M Buy
+35,020
New +$1.07M ﹤0.01% 1803

Other funds holding TMDX

HSBC Holdings's TMDX Position: Q3 2025 in Review

HSBC Holdings sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 3,231 shares — an estimated $432K sold.

HSBC Holdings first reported a position in TMDX in Q3 2021 and held it in 9 quarters. The position peaked at $5.65M in Q1 2024. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • HSBC Holdings reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 3,231 Transmedics shares in Q3 2025, an estimated $432K.
  • HSBC Holdings first reported a position in Transmedics in Q3 2021 and held it in 9 quarters.
  • HSBC Holdings's Transmedics position peaked at $5.65M in Q1 2024.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.